Intellex Acquires Expert by Big Village

We're thrilled to announce that Intellex has acquired Expert by Big Village, effective March 22, 2024. This strategic move enhances our capabilities and strengthens our commitment to delivering exceptional solutions to our customers.

Stay tuned for more updates on how this acquisition will benefit our clients and experts.

For inquiries or more information, please contact us at info@intellex.com.

×

Expert Details

Pharmaceutical Drug Development, Strategic Executive Management, Biopharma Mergers and Acquisitions

ID: 723580 Netherlands

Request Expert

Expert has over 20 years of experience. He is extensively active and has significant experience and expertise in Europe and the US in the areas of drug development and financing throughout Europe and the US. He was responsible for the overall management, business development and operations of the 160-man pharmaceutical clinical research organization in greater Europe. These responsibilities include Phase I through Phase IV clinical trials across all of Europe, Scandinavia and Israel.

He was responsible for all manner of strategy execution, executive management, investor relations, financings, and served as a member of the Board of Director. He also functioned as Chief Operating Officer and was responsible for all aspects of central nervous system drug development from basic research through Phase III clinical trials. He was responsible for new business acquisition of clinical stage projects across all therapeutic areas for the pharmaceutical industry in Europe. He was also responsible for the conduct of all programs to the highest standards of GCP and ICH Guidelines.

He was responsible for the clinical development programs in the therapeutic areas of cardiovascular, genitourinary and women's health. He was responsible for the conduct of company's development programs across the cardiovascular, respiratory and hormonal areas.

He is currently member of the Scientific Advisory Boards of 2 biotechnology companies and provides ad hoc guidance to scientific and development aspects of bio-pharma product candidates. He provides strategic executive management consulting services to two startup biotech companies on an ad hoc as needed basis as well as serving as intermediary in their financing efforts. He has provided drug development consulting services to protein development companies.

He is currently providing services in the area of financing of a startup company.

Education

Year Degree Subject Institution
Year: 1978 Degree: B.Sc. Subject: Physiology Institution: McGill University
Year: 1984 Degree: Medicine Subject: Medicine Institution: University of Leiden

Work History

Years Employer Title Department
Years: 2000 to 2006 Employer: Axonyx Inc. Title: President & CEO Department: executive management
Responsibilities:
Available upon request.
Years Employer Title Department
Years: 1997 to 1999 Employer: Chrysalis Clinical Services Title: General Manager and Vice President Department: Executive Management
Responsibilities:
Available upon request.
Years Employer Title Department
Years: 1995 to 1997 Employer: Forest Laboratories Title: Director Department: Director, Medical Department
Responsibilities:
Available upon request.
Years Employer Title Department
Years: 1993 to 1995 Employer: ClinTrials Research Title: Vice President Department: Medical and Regulatory Affairs, Program and Project Management
Responsibilities:
Available upon request.
Years Employer Title Department
Years: 1990 to 1993 Employer: Zambon UK Title: Medical Director Department: medical
Responsibilities:
Available upon request.

International Experience

Years Country / Region Summary
Years: 1990 to 2006 Country / Region: Europe Summary: He is extensively active and has significant experience and expertise in Europe in the areas of drug development and financing throughout Europe
Years: 1995 to 2006 Country / Region: USA Summary: He has extensive experience in the area of drug development and raising capital, both through the private and public routes in the USA
Years: 2005 to 2006 Country / Region: Far East Summary: He was responsible for the successful licensing activities of his company's lead asset to a pharmaceutical company in the far east
Years: 1997 to 2006 Country / Region: Israel Summary: He has been active in Israel both in the area of basic pharmaceutical research as well as clinical development activities
Years: 2004 to 2005 Country / Region: South Africa Summary: He managed the conduct of Phase III programs in RSA.

Career Accomplishments

Professional Appointments
He is past member of the Board of Directors of two publically traded US companies and currently serves on the Board of Directors of one private biopharma company.
Publications and Patents Summary
He has 9 publications, 10 scientific poster presentations, and 11 patents and/or patent applications

Language Skills

Language Proficiency
Englsih He is fluent in English
Dutch He is fluent in Dutch
French
German He is fluent in German

Fields of Expertise

Request Expert

Dev Tool:

Request: expert/pharmaceutical-drug-development-strategic-executive-management-biopharma-mergers-and-acquisitions
Matched Rewrite Rule: expert/([^/]+)(?:/([0-9]+))?/?$
Matched Rewrite Query: experts=pharmaceutical-drug-development-strategic-executive-management-biopharma-mergers-and-acquisitions&page=
Loaded Template: single-experts.php